Free Trial

BNP Paribas Financial Markets Has $465,000 Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

BNP Paribas Financial Markets reduced its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 88.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,712 shares of the company's stock after selling 28,355 shares during the quarter. BNP Paribas Financial Markets' holdings in Addus HomeCare were worth $465,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Dimensional Fund Advisors LP increased its stake in Addus HomeCare by 1.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock valued at $86,833,000 after buying an additional 10,434 shares during the period. Capital Research Global Investors acquired a new stake in shares of Addus HomeCare in the 4th quarter worth approximately $51,149,000. TimesSquare Capital Management LLC increased its stake in shares of Addus HomeCare by 28.5% during the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after acquiring an additional 78,835 shares during the period. Invesco Ltd. increased its stake in shares of Addus HomeCare by 6.5% during the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company's stock valued at $43,386,000 after acquiring an additional 21,266 shares during the period. Finally, Northern Trust Corp raised its holdings in Addus HomeCare by 3.3% during the fourth quarter. Northern Trust Corp now owns 285,872 shares of the company's stock worth $35,834,000 after purchasing an additional 9,122 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ADUS. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Macquarie raised their target price on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Stephens reaffirmed an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, Wall Street Zen cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $142.57.

Check Out Our Latest Stock Analysis on ADUS

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president now owns 7,796 shares of the company's stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 4.60% of the stock is owned by company insiders.

Addus HomeCare Trading Down 0.1%

Shares of NASDAQ ADUS traded down $0.14 during mid-day trading on Thursday, reaching $113.13. The company had a trading volume of 140,198 shares, compared to its average volume of 168,340. The company has a 50-day moving average price of $104.11 and a two-hundred day moving average price of $112.90. The stock has a market cap of $2.08 billion, a PE ratio of 25.89, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. During the same quarter last year, the company posted $1.21 EPS. Addus HomeCare's revenue for the quarter was up 20.3% on a year-over-year basis. On average, research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines